PURA Plans To Break Ground By July On New Hemp Brand Lifestyle Facilities
News provided by
Share this article
Share this article
DALLAS, Feb. 4, 2021 /PRNewswire/ Puration, Inc. (USOTC: PURA) today announced finalizing plans to break ground this summer on its recently acquired 70-acre property in Farmersville, Texas to begin construction on its new facilities.
PURA recently announced expanding upon its current EVERx CBD Sports Water business generating approximately $2 million in annual revenue with the launching a new hemp lifestyle brand business intended to raise overall market awareness and acceptance around the vast variety of industrial uses of hemp.
PURA is building partnerships with other hemp related industry companies to pursue pilot enterprises that will help demonstrate full utility of hemp.
(2)
Sandusky, Ohio (Newsfile Corp. - February 4, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today revealed plans to expand its nutraceutical product reach. The company plans to produce nutraceuticals for additional applications beyond the current focus on care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD).
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled, METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
In addition to PAOG s ongoing efforts to develop a pharmaceutical treatment for COPD, the company has announced engaging with the Puerto Rico Consortium for Clinical Investigation (PRCCI) to assist PAOG with developing its proprietary Cannabidiol (CBD) extract into a nutraceutical pr
PAO Group, Inc.: PAOG Confirms CBD Nutraceutical Development and Distribution Partners
Sandusky, Ohio (Newsfile Corp. - February 2, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed its plans to develop and distribute cannabis nutraceuticals with Alkame Holdings, Inc. (OTC Pink: ALKM) and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) as partners.
PAOG recently engaged with the Puerto Rico Consortium for Clinical Investigation (PRCCI) to assist PAOG with developing its proprietary Cannabidiol (CBD) extract into a nutraceutical product to provide care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD).
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS IN